WHO ICTRP trial

Effect of Three Turmeric- Boswellia Formulations in Exercise Induced Body Pain

CTRI/2021/02/031142 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2021/02/031142
Public title Effect of Three Turmeric- Boswellia Formulations in Exercise Induced Body Pain
Scientific title A Randomized Placebo Controlled double blind, double dummy, parallel arm study to assess the comparative efficacy of three Turmeric-Boswellia formulations in Adult Subjects with Exercise Induced Acute Musculoskeletal Pain - MSP200
Primary sponsor Arjuna Natural Private Limited
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2
Countries India
Interventions Intervention1: Rhuleave K: Turmeric Extract, Boswellia serrata extract, sesame oil 2 soft gel caps of 500mg, treatment duration 1 day. Intervention2: CBM030: Turmeric Extract, Boswellia serrata extract, MCT oil 2 soft gel caps of 500mg…
Registration date Sep 2, 2021
Target size 200
Secondary IDs AN-03PFK1120H3-WES05, version 1, 10 Nov 2020
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations